10X Genomics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -729.3% | – | – | – | – | +1,941.6% | |
| – | -9.3% | +80.9% | +169.2% | +48.5% | +16.8% | +32.2% | +0.2% | +0.2% | |
| – | +60.0% | +401.6% | +264.7% | +97.3% | +42.6% | +22.0% | -15.7% | -22.5% | |
| – | +122.8% | +276.8% | +2,453.8% | -73.0% | +43.6% | – | – | – | |
| – | +1,338.1% | +59.8% | -212.5% | – | – | – | -92.8% | +1,888.8% | |
| – | +78.6% | +537.5% | -10.2% | +163.8% | +30.0% | -62.4% | -75.0% | -52.1% | |
| – | +78.6% | +537.5% | -10.2% | +178.0% | +228.8% | – | -124.4% | -58.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | -92.0% | -47.4% | – | – | – | |
| – | – | -298.0% | +0.0% | -86.4% | +7.6% | – | – | – | |
| – | +411.9% | +293.5% | +13.1% | -92.5% | -55.2% | -13.6% | -20.2% | -37.7% | |
| – | +263.6% | +1,728.1% | -47.8% | -143.6% | – | – | -111.5% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.